Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Regulatory News (COA)

Share Price Information for Coats (COA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 84.90
Bid: 83.90
Ask: 84.10
Change: 0.00 (0.00%)
Spread: 0.20 (0.238%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 84.90
COA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

19 May 2021 07:00

RNS Number : 0607Z
Coats Group PLC
19 May 2021
 

19 May 2021

Coats Group plc

Trading update

 

Coats Group plc ('Coats', the 'Company' or the 'Group'), the world's leading industrial thread manufacturer, today announces a trading update for the period 1 January 2021 to 30 April 2021 ('the period'), ahead of its Annual General Meeting later today. Given the exceptional circumstances of 2020, we include 2019 detail in this statement.

 

Trading Update

· Strong operational performance and a return to organic growth vs 2019

· Pricing and productivity actions being successfully implemented to offset inflationary pressures

· Performance for the year anticipated to be slightly ahead of our previous expectations

 

Revenue vs 2020

Revenue vs 2019

Reported

CER1

Organic2

Reported

CER1

Organic3

Group

28%

27%

26%

3%

5%

1%

Apparel & Footwear

31%

30%

30%

(2)%

0%

0%

Performance Materials

18%

18%

14%

22%

24%

4%

 

All following references are on an organic CER basis.

 

Organic group sales for the period grew 26% year-on-year (1% versus 2019).

 

In Apparel and Footwear we saw improving momentum and recovery (up 30% versus 2020 and flat versus 2019). Robust volume growth resulted in increased factory activity. Against 2019 the core thread business (which represents c.85% of Apparel and Footwear) grew solidly (up 2%). Key markets performed well vs 2019, albeit zips are recovering at a slower pace.

 

Performance Materials was up 14% versus 2020 and 4% versus 2019, with all segments performing well and growing against 2019 and 2020, with the exception of Personal Protection. Personal Protection continues to be impacted by labour availability issues, specifically in the US Yarns business.

 

Pricing and productivity actions are being successfully implemented to offset inflationary pressures (raw materials, labour and freight inflation) in the supply chain.

 

In April we announced the completion of a three year $360 million ESG-linked bank refinancing (with the ability for two one-year extensions). Our committed debt facilities total $585 million across our Banking and US Private Placement group, with a range of maturities from 2024 through to 2027, and we currently have around $350 million of committed headroom against these banking facilities. As at 30 April 2021 our net debt (excluding IFRS16) was $162 million (31 December 2020 $181 million).

 

Rajiv Sharma, Chief Executive, commented:

"We are pleased to have seen recovery and positive momentum during the period, which resulted in a strong operational performance and a return to growth vs 2019. Whilst we remain vigilant around the ongoing Covid pandemic, given the improving end market sentiment, we anticipate that the recovery in our trading will continue and that our anticipated performance for the year will be slightly ahead of our previous expectations.

 

During the period we continued to implement self-help programs related to price and productivity. We also maintained focus on our strategic pillars of Digital, Innovation and Sustainability, which are a source of competitive advantage today and into the future. A strong balance sheet provides strategic optionality and positions us well to continue to win the recovery."

 

1

Constant Exchange Rate (CER) are 2020 and 2019 results restated at 2021 exchange rates;

2

Organic on a CER basis includes like-for-like contributions from Pharr HP (post acquisition date of February 2020);

3

Organic on a CER basis includes like-for-like contributions from Threadsol (post acquisition date of February 2019) and excludes contribution from Pharr HP (acquired in February 2020)

_________________________________________________________________________________________

 

Enquiry details

Investors

Victoria Huxster

Coats Group plc

+44 (0)7880 471 350

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0)20 3727 1374

_________________________________________________________________________________________

 

About Coats Group plc

Coats is the world's leading industrial thread company. At home in some 50 countries, Coats has a workforce of 17,000 people across six continents. Revenues in 2020 were US$1.2bn. Coats' pioneering history and innovative culture ensure the company leads the way around the world. It provides complementary and value added products, services and software solutions to the apparel and footwear industries. It applies innovative techniques to develop high technology Performance Materials threads, yarns and fabrics in areas such as Transportation, Telecommunications and Energy, and Personal Protection. Headquartered in the UK, Coats is a FTSE 250 company, a constituent of the FTSE4Good Index Series, a participant in the UN Global Compact and a member of the Ellen MacArthur Foundation. It has also committed to developing a long-term target to reach net-zero emissions by 2050, the highest level of ambition on climate under the Science Based Target Initiative.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKFBBCBKDQPD
Date   Source Headline
7th May 20241:16 pmRNSHolding(s) in Company
5th Apr 202410:50 amRNSBlock listing Interim Review
25th Mar 20242:16 pmRNSDirector/PDMR Shareholding
25th Mar 20242:15 pmRNSDirector/PDMR Shareholding
13th Mar 20243:55 pmRNSAnnual Financial Report
8th Mar 202412:27 pmRNSDirector/PDMR Shareholding
8th Mar 202412:25 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNS2023 Full Year Results
29th Feb 202410:03 amRNSHolding(s) in Company
29th Feb 20249:59 amRNSHolding(s) in Company
14th Dec 20232:13 pmRNSDirector Declaration
7th Dec 20237:00 amRNSSwitch off of Pension Deficit Repair Payments
22nd Nov 20237:00 amRNSTrading Statement
21st Nov 20239:22 amRNSHolding(s) in Company
16th Nov 20232:02 pmRNSHolding(s) in Company
15th Nov 20239:00 amRNSChange of Senior Independent Director
1st Nov 20231:38 pmRNSHolding(s) in Company
9th Oct 202312:10 pmRNSBlock listing Interim Review
5th Oct 20237:00 amRNSDirectorate Change
27th Sep 202312:32 pmRNSDirector/PDMR Shareholding
25th Sep 20232:56 pmRNSHolding(s) in Company
14th Sep 202311:47 amRNSHolding(s) in Company
1st Sep 20237:00 amRNSDeal Completion
4th Aug 202311:54 amRNSDirector/PDMR Shareholding
4th Aug 202311:48 amRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSDivestment of European Zips
6th Jun 20239:00 amRNSAppointment of Joint Corporate Broker
22nd May 202310:28 amRNSDirector Declaration
17th May 20234:23 pmRNSResult of AGM
17th May 20237:00 amRNSTrading Statement
12th Apr 202312:47 pmRNSBlock listing Interim Review
27th Mar 20234:15 pmRNSHolding(s) in Company
22nd Mar 202312:39 pmRNSHolding(s) in Company
20th Mar 20232:41 pmRNSDirector/PDMR Shareholding
20th Mar 20232:40 pmRNSDirector/PDMR Shareholding
17th Mar 20234:44 pmRNSDirectorate Change
14th Mar 202312:38 pmRNSHolding(s) in Company
14th Mar 202312:25 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSDirector/PDMR Shareholding
9th Mar 202311:23 amRNSAnnual Financial Report
3rd Mar 202312:20 pmRNSDirector/PDMR Shareholding
3rd Mar 202312:17 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNS2022 Full Year Results
23rd Feb 202310:31 amRNSHolding(s) in Company
20th Feb 20237:00 amRNS$250m US private placement
16th Feb 20239:19 amRNSHolding(s) in Company
9th Dec 20229:23 amRNSHolding(s) in Company
6th Dec 20227:00 amRNSUK pension scheme update
23rd Nov 20227:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.